---
title: "Perrigo Reports A Loss From Cont. Opns. In Q1, Sales Decline"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285363744.md"
description: "Perrigo Company plc (PRGO) reported a significant loss in Q1, with a net loss from continuing operations of $389.8 million, compared to a breakeven profit last year. The decline was attributed to $330.8 million in impairment charges and $75.1 million in restructuring costs. Sales fell 7.2% to $969.2 million, driven by lower consumption in the U.S. and Europe. For the full year, Perrigo expects net sales to decline by 5.5% to 1.5% and adjusted EPS between $2.00 and $2.30."
datetime: "2026-05-06T11:10:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285363744.md)
  - [en](https://longbridge.com/en/news/285363744.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285363744.md)
---

# Perrigo Reports A Loss From Cont. Opns. In Q1, Sales Decline

Add  as your preferred news source on Google

 Add Now

Perrigo Company plc (PRGO), a provider of Consumer Self-Care Products, on Wednesday reported a significantly weaker first-quarter performance, as large impairment and restructuring charges weighed heavily on profitability. Sales also declined in the quarter.

The company posted a net loss from continuing operations of $389.8 million or $2.81 per share, compared with a profit of $0.1 million or breakeven per share in the same period last year, primarily due to $330.8 million in impairment charges and higher restructuring costs of $75.1 million.

Excluding one-time items, earnings were $0.43 per share, down from $0.60 per share a year earlier.

Core adjusted EPS was $0.40, a 20% decrease from the prior year.

Operating income turned to a loss of $372.3 million, versus a profit of $46.9 million.

Net sales declined 7.2% to $969.2 million from $1.044 billion last year, mainly driven by lower consumption across both the U.S. and Europe.

Core net sales were $842 million, 8.3% down year over year, while Core organic net sales decreased 11%.

For the full year, the company expects net sales to decline 5.5% to 1.5%, and adjusted EPS in the range of $2.00 to $2.30.

Core organic net sales are projected to range from a decline of 3.5% to growth of 0.5%, while core adjusted EPS is expected to be between $2.25 and $2.55.

For comments and feedback contact: editorial@rttnews.com

Business News

### Related Stocks

- [PRGO.US](https://longbridge.com/en/quote/PRGO.US.md)

## Related News & Research

- [03:15 ETCIGL, YOOV Deadline: CIGL, YOOV Investors Have Opportunity to Lead Concorde International Group Ltd. Securities Fraud Lawsuit](https://longbridge.com/en/news/287021785.md)
- [22:13 ETGLOB Investors Have Opportunity to Lead Globant S.A. Securities Fraud Lawsuit](https://longbridge.com/en/news/286842370.md)
- [Does Slower Organic Growth Undermine the Automation and M&A Story at Applied Industrial Technologies (AIT)?](https://longbridge.com/en/news/286647498.md)
- [20:11 ETLU Deadline: LU Investors Have Opportunity to Lead Lufax Holding Ltd Securities Fraud Lawsuit First Filed by the Firm](https://longbridge.com/en/news/286979305.md)
- [Stellantis N.V. (STLA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit](https://longbridge.com/en/news/286607688.md)